ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,025.99
      -0.95%
      US Tech 100
      20,874.00
      -1.46%
      Dow Jones
      44,303.40
      -0.99%
      Brent Oil
      74.565
      0.00%
      Bitcoin
      96,319.17
      -0.15%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Australia
      5. ASX

      6. Clinuvel Pharmaceuticals Limited (CUV) Quote

      Clinuvel Pharmaceuticals Limited

      Clinuvel Pharmaceuticals Limited (CUV)

      CUV Ventures Corp
      11.45
      -0.12
      (-1.04%)
      Closed February 09 12:00AM
      Delayed by 20 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      11.45
      Bid
      11.45
      Ask
      11.64
      Volume
      76,528
      11.45 Day's Range 11.70
      11.16 52 Week Range 17.71
      Market Cap
      573.688M
      Previous Close
      11.57
      Open
      11.60
      Last Trade
      4996
      @
      11.47
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      114,547
      Shares Outstanding
      50,103,765
      Dividend Yield
      -
      PE Ratio
      16.10
      Earnings Per Share (EPS)
      0.71
      Revenue
      88.74M
      Net Profit
      35.64M

      About Clinuvel Pharmaceuticals Limited

      Sector
      Medicinal Chems,botanicl Pds
      Industry
      Drugs-health R&d/testing Labs
      Website
      www.clinuvel.com
      Headquarters
      Melbourne, Victoria, Aus
      Founded
      2000
      Clinuvel Pharmaceuticals Limited is listed in the Medicinal Chems,botanicl Pds sector of the Australian Stock Exchange with ticker CUV. The last closing price for Clinuvel Pharmaceuticals was AUD11.57. Over the last year, Clinuvel Pharmaceuticals shares have traded in a share price range of AUD 11.16 to AUD 17.71.

      Clinuvel Pharmaceuticals currently has 50,103,765 shares outstanding. The market capitalization of Clinuvel Pharmaceuticals is AUD579.70 million. Clinuvel Pharmaceuticals has a price to earnings ratio (PE ratio) of 16.10.

      Ask ADVFN Intelligence (AI)

      CUV Latest News

      More News

      Europe Approves Novel Australian Drug Developed for Rare Sun Disease

      The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the European Medicines Agency (EMA...

      October 24 2014
      Business Wire

      Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study

      Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study Primary endpoint shows a strong statistical trend in pain-free exposure following the treatment of the 'orphan...

      November 11 2013
      PR Newswire (US)

      Clinuvel Files European Marketing Authorisation Application for SCENESSE® (afamelanotide)

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class...

      February 06 2012
      Business Wire

      Clinuvel announces positive results of first Phase II US study of SCENESSE® in orphan disease erythropoietic protoporphyria ...

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY), a global biopharmaceutical company with unique expertise on the interaction of light and human skin...

      November 03 2011
      Business Wire

      EMA acknowledges Clinuvel’s novel drug filing in Europe in 2011

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it held a constructive Pre-Submission Meeting with the European Medicines Agency...

      May 12 2011
      Business Wire

      Successful Drug Trial Results for Light Intolerant 'Shadow Jumpers'

      A new Australian drug has been shown to assist in protecting patients with a rare genetic disorder that makes their skin toxic to light and UV, and previously forced them to...

      July 13 2010
      Business Wire

      Clinuvel Unveils SCENESSE® Following European Brand Approval

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that the European Medicines Agency (EMA) Name Review Group (NRG) and the Agency’s...

      May 18 2010
      Business Wire

      Preliminary Results in Clinuvel’s Phase III Porphyria Trial

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it has obtained promising 4-months results in testing afamelanotide in a multicentre...

      December 21 2009
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.58-4.82128013312.0312.4911.3710009011.76103077DE
      4-0.35-2.9661016949211.812.4911.1610993911.72281142DE
      12-2.25-16.423357664213.714.0511.1611454712.28474203DE
      26-2.32-16.848220769813.7715.9911.169690813.28013068DE
      52-4.29-27.255400254115.7417.7111.1610191514.13363652DE
      156-11.4-49.890590809622.8528.7211.1610010917.07023213DE
      260-13.91-54.850157728725.3644.6711.1612085121.13683877DE

      CUV - Frequently Asked Questions (FAQ)

      What is the current Clinuvel Pharmaceuticals share price?
      The current share price of Clinuvel Pharmaceuticals is AUD 11.45
      How many Clinuvel Pharmaceuticals shares are in issue?
      Clinuvel Pharmaceuticals has 50,103,765 shares in issue
      What is the market cap of Clinuvel Pharmaceuticals?
      The market capitalisation of Clinuvel Pharmaceuticals is AUD 579.7M
      What is the 1 year trading range for Clinuvel Pharmaceuticals share price?
      Clinuvel Pharmaceuticals has traded in the range of AUD 11.16 to AUD 17.71 during the past year
      What is the PE ratio of Clinuvel Pharmaceuticals?
      The price to earnings ratio of Clinuvel Pharmaceuticals is 16.1
      What is the cash to sales ratio of Clinuvel Pharmaceuticals?
      The cash to sales ratio of Clinuvel Pharmaceuticals is 6.46
      What is the reporting currency for Clinuvel Pharmaceuticals?
      Clinuvel Pharmaceuticals reports financial results in AUD
      What is the latest annual turnover for Clinuvel Pharmaceuticals?
      The latest annual turnover of Clinuvel Pharmaceuticals is AUD 88.74M
      What is the latest annual profit for Clinuvel Pharmaceuticals?
      The latest annual profit of Clinuvel Pharmaceuticals is AUD 35.64M
      What is the registered address of Clinuvel Pharmaceuticals?
      The registered address for Clinuvel Pharmaceuticals is LEVEL 11, 535 BOURKE STREET, MELBOURNE, VICTORIA, 3000
      What is the Clinuvel Pharmaceuticals website address?
      The website address for Clinuvel Pharmaceuticals is www.clinuvel.com
      Which industry sector does Clinuvel Pharmaceuticals operate in?
      Clinuvel Pharmaceuticals operates in the DRUGS-HEALTH R&D/TESTING LABS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KALKalgoorlie Gold Mining Ltd
      AUD 0.086
      (273.91%)
      		100.5M
      E79E79 Gold Mines Ltd
      AUD 0.038
      (100.00%)
      		14.68M
      SLZOSultan Resources Ltd
      AUD 0.002
      (100.00%)
      		335.71k
      TMSOTennant Minerals Ltd
      AUD 0.002
      (100.00%)
      		500k
      BP8BPH Global Ltd
      AUD 0.003
      (50.00%)
      		1.45M
      NACONAOS Ex50 Opportunities Company Limited
      AUD 0.001
      (-50.00%)
      		31.7k
      ADNOCAndromeda Metals Limited
      AUD 0.001
      (-50.00%)
      		750k
      VPRVolt Group Ltd
      AUD 0.001
      (-50.00%)
      		300.11k
      EELENRG Elements Ltd
      AUD 0.001
      (-50.00%)
      		1.05M
      UNTOAUnith Ltd
      AUD 0.003
      (-40.00%)
      		50k
      1TTThrive Tribe Technologies Ltd
      AUD 0.002
      (-33.33%)
      		145.77M
      KALKalgoorlie Gold Mining Ltd
      AUD 0.086
      (273.91%)
      		100.5M
      SYASayona Mining Limited
      AUD 0.025
      (2.04%)
      		98.07M
      MYRMyer Holdings Limited
      AUD 0.89
      (5.33%)
      		65.63M
      POSPoseidon Nickel Limited
      AUD 0.0055
      (22.22%)
      		57.15M

      Discussion

      View Full Feed
      StayHumble StayHumble 1 minute ago
      Mother Earth’s Stores Double $HCWC💹Revenue to $75Million+✅ @healthiercmc
      https://www.healthiercmc.com/news/20220210-mother-earths-storehouse
      https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/HCMC_LDMicroOct2022.pdf
      HCWC
      Disquisition Disquisition 1 minute ago
      hahah you are so easy to trigger!!!

      Replying OVER and OVER and OVER to a single post bwahahahahahah!!!

      But here’s some good news for you:

      There are only 3 years, 11 months, and 11 days until TRUMP’s term is done…

      …and JD Vance’s 8 YEARS beg
      StayHumble StayHumble 2 minutes ago
      "I ShortNaked🔥24/7" tops the list per X MorganStanleyEmployee
      “Gaming Wall Street”- HBO Documentary


      Ex Morgan Stanley employee explains the situation about shorting and naked shorting perfectly!


      Again, this is a MUST WATCH video for
      BigBang BigBang 5 minutes ago
      If we have a prospect of payment, wouldn't banks familiar with the matter offer bridging loans?Why? This has been mentioned before, however, I don’t see the connection. Why would a bank take the initiative to offer a loan? I always thought that it is the consumer that would request a loan from a ban
      COOP
      brooklyn13 brooklyn13 5 minutes ago
      During the run up to the Presidential election, I guy who I know a little bit, a progressive on most things, would stand alongside a pretty busy road during morning rush hour with a sign that read simply, "Genocide Joe". And of course the demonstrations on campuses, protests in front of Israeli sto
      shadolane shadolane 6 minutes ago
      I've been reading all of your posts as wells as those by 4u2nv2 and it seems you are both on the same side of the topic differing only
      by strategy issues. And maybe some history.

      Working together seems could have very good results.

      Hopefully you will both come to
      IFUS
      Paulie Pennies Paulie Pennies 6 minutes ago
      China Telecom Collaborated with Conflux and LayerZero for a blockchain-based SIM card (BSIM) project.

      Telco companies in blockchain. Several telecommunications companies have explored or implemented blockchain technology in various capacities.

      China Mobile: Has integrat
      ASII
      Stern is Bald Stern is Bald 7 minutes ago
      SS and VA benefits have been in the GOPs eyes for decades and theres so much info on that I think you should google it. And example is them trying to push back your age to be eligible to collect.

      Also Trumps statement he stopped condoms to Gaza was 50 million and theres zero evidence
      FNMA
      Rattlershehe Rattlershehe 8 minutes ago
      Sounds to me like you're implying that Nick is like, crown king. Please do not compare the two. 
      AAGC
      Hoskuld Hoskuld 9 minutes ago
      Genz2, was just re-reading your note. Do you think that somehow Tesla has more information than OnStar does? It doesn't. That is really not a big deal but if you take on a position based on an emotional position (making a false statement that feels good) then you can lose a lot of money. Best to
      TSLA
      StayHumble StayHumble 11 minutes ago
      💹wow!✅a $5M $HCMC✅💹BUYBACK💹 💹 💹

      -A buyback of up to $5M of $HCMC common stock.

      -A spinoff of certain HCMC assets into a new publicly traded company

      -A stock dividend to $HCMC shareholders of the stock
      HCMC
      Locknload56 Locknload56 12 minutes ago
      If you bothered to research you would know the orange man is trying to cut 4 T so he can extend the tax cut for the wealthy past 2025.
      NWBO
      Huggy Bear Huggy Bear 12 minutes ago
      Hilarious.
      KEGS
      Just the facts maam Just the facts maam 15 minutes ago
      It all makes sense now. Merck is almost definitely the partner.

      ANIP announce the agreement to acquire Corti from Merck on September 21, 2015.

      https://investor.anipharmaceuticals.com/node/9501/html Corti announcement

      The following day ANIP obtains Co
      ANIP
      StayHumble StayHumble 18 minutes ago
      SEC💹Catches🎅🏿+👽ArtificiallyDeflating Prices✅2Buy Shares Cheaper wow

      6, 12, 2023. —
      SEC charged investment adviser Sabby Management LLC & managing partner,Hal D. Mintz,w/ fraud in connection w/ a long running scheme involving misrepres
      UBQU
      Duma Duma 23 minutes ago
      Big game today, enjoy.
      PEACHMAN PEACHMAN 23 minutes ago
      IFUS has always been built on science and manufacturing technology.The key to IFUS is Nutri-mastic and the 72 ionic minerals.It is involved in every product.It is the key to making other products better.

      I believe on one podcast interview Marc said I step in a puddle of mud and I end
      IFUS
      CanItBThisEZ2Make CanItBThisEZ2Make 23 minutes ago
      BEST SELLERS RANK (BSR) IS 786 35 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
      https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
      https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

      NOTE: In theory, when BSR Value Dec
      SRMX
      StayHumble StayHumble 23 minutes ago
      KramerNakedShorted✅4Bill+$DBMM shares4Charity, Idiot?🔥💹

      Source: TDA 2014 Chart https://investorshub.advfn.com/uimage/uploads/2023/1/29/cpbxb2014_dbmm_trade_data.png Source: https://fintel.io/s/us/dbmm
      https://investorshub.advfn.com/uimage/uploads/20
      DBMM
      Bubae Bubae 25 minutes ago
      You really should show a link to support at least one point of your rant. If there really is 500 million sold short here (not) I would take that to mean this stock is toxic. Those who short a stock conduct real due diligence. You know, like what I provide on this board complete with links to the fil
      RDAR

      Your Recent History

      ASX
      CUV
      Clinuvel Pharmaceuticals
      BOV
      P2LT34
      Palantir Technologies
      BIT
      BCM
      Biancamano
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads